A dialysis fluid system includes a dialysis fluid inlet; a dialysis fluid outlet; a pump positioned and arranged to pump dialysis fluid through the dialysis fluid inlet and the dialysis fluid outlet; and an inductive heater located between the dialysis fluid inlet and the dialysis fluid outlet, the inductive heater including a fluid flowpath positioned and arranged to receive non-heated dialysis fluid from the dialysis fluid inlet and to output heated dialysis fluid to the a dialysis fluid outlet, a conductive heater element located within the fluid flowpath so as to be or act as a secondary coil of a transformer, and a primary coil of the transformer located outside of the fluid flowpath and positioned so as to magnetically induce a current into the conductive heater element, causing the conductive heater element and surrounding fluid to heat.

A dialysis fluid system includes a dialysis fluid inlet; a dialysis fluid outlet; a pump positioned and arranged to pump dialysis fluid through the dialysis fluid inlet and the dialysis fluid outlet; and an inductive heater located between the dialysis fluid inlet and the dialysis fluid outlet, the inductive heater including a fluid flowpath positioned and arranged to receive non-heated dialysis fluid from the dialysis fluid inlet and to output heated dialysis fluid to the a dialysis fluid outlet, a conductive heater element located within the fluid flowpath so as to be or act as a secondary coil of a transformer, and a primary coil of the transformer located outside of the fluid flowpath and positioned so as to magnetically induce a current into the conductive heater element, causing the conductive heater element and surrounding fluid to heat.

A system and method for controlling a renal therapy device is provided. The system comprises a controller for performing a method comprising: receiving a first power level of a first battery to determine if the first power level of the first battery is above a threshold value and receiving a second power level of a second battery to determine if the second power level of the second battery is above the threshold value. When the first power level is above the threshold value, the controller causes the renal therapy device to be powered by the first battery. When the first power level is below the threshold value, and the second power level is above the threshold value, the controller causes the renal therapy device to be powered by the second battery. The first battery is electrically isolated from the second battery.

A system and method for controlling a renal therapy device is provided. The system comprises a controller for performing a method comprising: receiving a first power level of a first battery to determine if the first power level of the first battery is above a threshold value and receiving a second power level of a second battery to determine if the second power level of the second battery is above the threshold value. When the first power level is above the threshold value, the controller causes the renal therapy device to be powered by the first battery. When the first power level is below the threshold value, and the second power level is above the threshold value, the controller causes the renal therapy device to be powered by the second battery. The first battery is electrically isolated from the second battery.

An apparatus includes a blood-flow-management assembly shaped to define a cylindrical aperture. The blood-flow-management assembly includes a blood collector having drainage holes configured to direct blood to a guide surface positioned below the blood collector. The guide surface may further include ribs that manage blood flow along the guide surface.

The present invention is directed generally to a method and apparatus for human brain neuroprotection during surgery. The invention includes use of a heart-lung machine to generate periodic rectangular pulsation of blood flow. The invention uses a non-invasive CA monitor to continuously record transient functions such as dynamic autoregulation functions of a human brain cerebrovascular autoregulation system and process the data to generate an alarm to indicate CA impairment and take steps to minimize the CA impairment event.

The present disclosure pertains to control units for non-occlusive blood pumps of an extracorporeal circulatory support as well as systems comprising such a control unit and corresponding methods. Accordingly, a control unit for a non-occlusive blood pump of an extracorporeal circulatory support is configured to receive a flow value of the extracorporeal circulatory support, to receive a measurement of an arterial pressure and an ECG signal of a supported patient over a predetermined period of time, to determine a mean arterial pressure of the extracorporeal circulatory support or of the supported patient from the measurement of the arterial pressure and an energy equivalent pressure from the flow value and the arterial pressure.

The present disclosure pertains to control units for non-occlusive blood pumps of an extracorporeal circulatory support as well as systems comprising such a control unit and corresponding methods. Accordingly, a control unit for a non-occlusive blood pump of an extracorporeal circulatory support is configured to receive a flow value of the extracorporeal circulatory support, to receive a measurement of an arterial pressure and an ECG signal of a supported patient over a predetermined period of time, to determine a mean arterial pressure of the extracorporeal circulatory support or of the supported patient from the measurement of the arterial pressure and an energy equivalent pressure from the flow value and the arterial pressure.

An extracorporeal circulation management device pumps blood in synchronization with heartbeats of a patient based on measurements of blood flow. Maximum and minimum blood flow measurement samples are compared with upper and lower threshold values to identify candidate timing for a systolic phase and diastolic phase of the heartbeat. During pulsatile pumping of the blood using the candidate timing, differences in the pulsatile flow measurements are determined. Based on the size of the difference, a final correction may be made to identification of the systolic and diastolic phases, and the corrected phase information is used to start and stop the motor unit.

An extracorporeal circulation management device pumps blood in synchronization with heartbeats of a patient based on measurements of blood flow. Maximum and minimum blood flow measurement samples are compared with upper and lower threshold values to identify candidate timing for a systolic phase and diastolic phase of the heartbeat. During pulsatile pumping of the blood using the candidate timing, differences in the pulsatile flow measurements are determined. Based on the size of the difference, a final correction may be made to identification of the systolic and diastolic phases, and the corrected phase information is used to start and stop the motor unit.